NCCS represents the millions of Americans who live with, through and beyond a cancer diagnosis. But the cancer experience is not the same for everyone. Gains in cancer survival due to advances in treatment and screening are not shared by all who are diagnosed with cancer. Outcomes vary significantly based on a number of factors, including race/ethnicity, socioeconomic status, health insurance status, and geographic location. According to researchers from the American Cancer Society, a quarter of the approximately 600,000 annual cancer deaths in the United States could be prevented if everyone had access to the same prevention, screening, and treatment.
NCCS works on policy efforts to address health equity and reducing disparities in outcomes. The problem of health equity is complex, as some of the factors that lead to inequity are deeply rooted in social determinants of health and systemic and institutional barriers. Many of the policies that would improve access to care would contribute to reducing disparities. The Affordable Care Act (ACA), including its expansion of Medicaid, has reduced disparities in access to care and mortality rates, compared to states that chose not to expand Medicaid.
“Historically, racial/ethnic minorities, the poor, and the uninsured are less likely to receive evidence‐based cancer prevention and screening, and they are more likely to be diagnosed with advanced disease. Racial/ethnic minorities, the poor, and the uninsured are less likely to receive effective cancer treatment and have poorer survival after diagnosis. A substantial proportion of insured Americans are underinsured, and their access to high‐quality care is also limited. These underinsured populations are also less likely to receive evidence‐based preventive care and, when diagnosed with cancer, they are less likely to receive optimal care, including cancer surgery, radiation therapy, and systemic therapies, and they have poorer survival after a cancer diagnosis. Although some disparities in cancer care by race are decreasing, disparities by socioeconomic status and state of residence are increasing.”Yabroff, K Robin et al. “Minimizing the burden of cancer in the United States: Goals for a high-performing health care system.” CA: a cancer journal for clinicians vol. 69,3 (2019): 166-183. doi:10.3322/caac.21556
Protections for Pre-Existing Conditions and Coverage Standards at Risk — Patient groups are urging the Fifth Circuit Court of Appeals to prioritize patient protections, including those for people with pre-existing conditions, when it hears oral arguments today in the case Texas v. United States. The case is being appealed after a lower court ruling that the entire health care law should be struck down because Congress repealed the individual [...]
https://canceradvocacy.org/wp-content/uploads/2018/07/NCCS-News-Cancer-Policy-Matters.jpg6001200actualizehttps://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.pngactualize2019-07-09 10:52:592020-07-06 10:11:53Patient Groups Urge Court to Prioritize Patients and Uphold Health Care Law
Today marks one year since the Trump administration announced it would not defend the ACA and that the entire law should be struck down, including protections for pre-existing conditions. In just one month, oral arguments are scheduled in the Fifth Circuit Court of Appeals. New research released last week at the annual American Society of Clinical Oncology (ASCO) meeting shows that the ACA’s Medicaid expansion reduced racial disparities [...]
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png250250actualizehttps://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.pngactualize2019-06-07 16:22:342020-07-06 10:11:54Health Care Roundup: ACA Erased Key Racial Cancer Disparity; ‘Survivor’ Debate; Isolation in Survivorship; Remembering Two Cancer Pioneers; More
Comparing Health Care Proposals – As Medicare-for-all and other public health care proposals continue to be released by Members of Congress, Kaiser Family Foundation created a great interactive summary which they update regularly to compare these plans. Most recently, Senator and presidential candidate Bernie Sanders introduced his Medicare-for-all bill in the Senate. | Surprise Billing – Surprise medical billing has been getting a lot of attention [...]
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png250250actualizehttps://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.pngactualize2019-04-19 15:58:042019-04-19 15:58:04Health Care Roundup: Health Care Proposals Compared; ‘Surprise Billing’ Under Scrutiny; How Cancer Disrupts Young Adults’ Lives; Medicare Part D; More
Loss of Patient Protections Would Raise Barriers to Health Insurance — Seventeen patient groups representing millions of Americans with pre-existing conditions filed an amicus curiae (“friend-of-the-court”) brief today in the U.S. Court of Appeals for the Fifth Circuit in the case Texas v. United States, citing the devastating impact patients would face should the court uphold the District Court ruling to invalidate the Affordable Care Act (ACA). [...]
https://canceradvocacy.org/wp-content/uploads/2018/10/NCCS-Blog-CPM-Logo.jpg6001200actualizehttps://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.pngactualize2019-04-01 05:15:522019-04-01 05:15:5217 Patient Groups Urge Appeals Court to Uphold Health Care Law
There was a steady stream of health care news this past week, including court rulings regarding Medicaid work requirements and association health plans, as well as a major shift in the administration’s position on the Affordable Care Act (ACA) lawsuit. Democrats introduced new legislation to strengthen the ACA on its 9-year anniversary. Here’s what you need to know about these developments: The Justice Department announced that the Trump [...]
Kansas House Sends Medicaid Expansion to Senate – This week, Kansas is one step closer to expanding Medicaid in the state, after lawmakers passed a bill in the House that would add coverage for an estimated 150,000 Kansans. The expansion bill will head to the Senate where the outcome is unknown. From the Wichita Eagle: “The plan expands eligibility for medical assistance to all adults who are under 65 and make less than 133 percent [...]
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png250250actualizehttps://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.pngactualize2019-03-22 15:53:242019-03-22 15:53:24Health Care Roundup: Kansas Moves Medicaid Expansion; CDC Study: How Patients Reduce Their Drug Costs; Where EHRs Went Wrong; More
FDA Commissioner Gottlieb Announces Resignation — On Tuesday, Dr. Scott Gottlieb, commissioner of the Food and Drug Administration, announced that he would be resigning in the next month. Two focus areas during Commissioner Gottlieb’s tenure at the FDA include curbing vaping and making generic drugs more accessible. Dr. Gottlieb says he is stepping down from his role in order to spend more time with his family. Congress Holds [...]
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png250250actualizehttps://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.pngactualize2019-03-08 16:04:402019-03-08 16:04:40Health Care Roundup: FDA’s Gottlieb Steps Down; Hearings on High Costs; Coping with Cancer’s Aftermath; Why Insurers Deny Claims; More
NCCS and member organizations of the Cancer Leadership Council (CLC) submitted comments to the HHS in response to the agency’s Notice of Benefits and Payment Parameters for 2020. The Notice contains rules and provisions that will apply to the individual market (the Affordable Care Act marketplace), and small group health insurance markets. The letter states NCCS’ concerns about specific provisions that may threaten cancer patients’ access [...]
https://canceradvocacy.org/wp-content/uploads/2017/10/NCCS-Policy-Comments-HHS-bldg.jpg6001200actualizehttps://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.pngactualize2019-03-04 09:24:002019-03-04 09:24:00NCCS Concerned That Proposed ACA Rule Changes Could Raise Costs for Patients and Disrupt Treatment
The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.
The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.
Share Your Story
NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.
Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action